Merck in collaboration to develop coronavirus vaccine, with clinical trials to start this year
Merck said the vaccine candidate would use the platform that's the basis for its Ebola Zaire virus vaccine.
“I think we’ll have to have one more cycle of this virus in the fall heading into the winter before we get to a vaccine.” Dr. Scott Gottlieb says he thinks having a vaccine available for widespread use for the general population is “probably a 2021 event.”
"I'm not in a position today to say exactly what the timeline will be. We're going to move as quickly and as responsibly as we can," Merck CEO Ken Frazier said on developing a potential vaccine against the coronavirus.